CIK 0001447028
- Non-accelerated filer
- Smaller reporting company
Arbutus Biopharma Corp
Sign in to watch- Ticker
- ABUS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980597776
- Phone
- +1 604-419-3200
- Business address
- 701 VETERANS CIRCLE, WARMINSTER, PA, 18974
- Former names
- TEKMIRA PHARMACEUTICALS CORP, TEKMIRA PHARMACEUTICALS Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-01 | Howard Elizabeth EVP, GC, Compliance | Grant or award | +69,700 | 86,024 | ||
| 2023-02-01 | Howard Elizabeth EVP, GC, Compliance | Grant or award · Stock Option (Right to Buy) | +278,700 | 278,700 | ||
| 2022-01-20 | Howard Elizabeth Chief Compliance Officer | Grant or award · Stock Option (Right to Buy) | +237,500 | $2.81 | $667K | 237,500 |
| 2021-02-13 | Howard Elizabeth Chief Compliance Officer | Grant or award · Stock Options | +200,000 | 200,000 | ||
| 2020-02-17 | Howard Elizabeth Chief Compliance Officer | Grant or award · Stock Options | +79,500 | 79,500 | ||
| 2019-03-01 | Howard Elizabeth Executive VP & General Counsel | Grant or award · Employee Stock Option (Right to Buy) | +137,500 | 137,500 | ||
| 2018-04-16 | Howard Elizabeth Exec. VP & General Counsel | Grant or award · Employee Stock Option (Right to Buy) | +150,000 | 150,000 | ||
| 2017-03-24 | Howard Elizabeth Exec. VP & General Counsel | Grant or award · Employee Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2016-03-15 | Howard Elizabeth Exec. VP & General Counsel | Grant or award · Employee Stock Option (Right to Buy) | +120,000 | 120,000 |
Page 1 of 1 · 9 trades